Archives
One Shot at a Cure: How Roman Kniazev Is Winning the Biotech Survival Game
Roman Kniazev, CEO of Nuravax, has emerged as one of biotech's most effective fundraisers, securing a mix of competitive grants and private investments to advance innovative drug programs. Kniazev shared some practical insights on navigating biotech's complex fundraising and clinical development landscape.
23andMe Sells DNA Database to Regeneron in £256m Deal: Is Your Data Safe?
23andMe's sale to Regeneron transfers genetic data for drug development, raising privacy issues and concerns over consumer control and benefits.
Levi's Sells Iconic Dockers Brand to Authentic, Eyes Global Expansion
Levi's sells Dockers to Authentic Brands for $311 million to focus on denim, global growth, and core brand strategy.
Japan's Agriculture Minister Quits After Controversial Rice Comment
Japan's agriculture minister resigns after controversial rice comment amid rising food prices and public backlash.

















